Rita Nanda, MD, on Triple-Negative Breast Cancer: Emerging Therapeutic Strategies

April 12, 2021 By The ASCO Post Staff

Rita Nanda, MD, of the University of Chicago, discusses the latest data on novel treatment strategies for triple-negative breast cancer, including immune checkpoint, PARP, and ATK inhibitors; antibody-drug conjugates; and targeting the androgen receptor.

Related Content